Mortality and comorbidities in patients with multiple sclerosis compared with a population without multiple sclerosis: An observational study using the US Department of Defense administrative claims database

Multiple Sclerosis and Related Disorders

Volumn 4, Issue 6, 2015, Pages 546-554

  Capkun, Gorana ^a   Dahlke, Frank ^a   Lahoz, Raquel ^a   Nordstrom, Beth ^b   Tilson, Hugh H ^c   Cutter, Gary ^d   Bischof, Dorina ^a   Moore, Alan ^a   Simeone, Jason ^b   Fraeman, Kathy ^b   Bancken, Fabrice ^a   Geissbühler, Yvonne ^a   Wagner, Michael ^e   Cohan, Stanley ^f  

^a NOVARTIS PHARMA AG   (Switzerland)

^b EVIDERA   (United States)

^c IL   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^e NAVAL MEDICAL CENTER PORTSMOUTH   (United States)

^f PROVIDENCE ST VINCENT MEDICAL CENTER   (United States)

Author keywords

Administrative claims; Causes of death; Comorbidities; Multiple sclerosis

Indexed keywords

AZATHIOPRINE; BETA1A INTERFERON; CORTICOSTEROID; CYCLOPHOSPHAMIDE; FINGOLIMOD; GLATIRAMER; INTERFERON BETA SERINE; METHOTREXATE; MITOXANTRONE; NATALIZUMAB;

ADULT; AGE DISTRIBUTION; ARTICLE; BRAIN ISCHEMIA; BREAST CANCER; CAUSE OF DEATH; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CROHN DISEASE; DATA BASE; DEPRESSION; DIABETES MELLITUS; FEMALE; FOLLOW UP; GOVERNMENT; HEART INFARCTION; HUMAN; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; MELANOMA; MORTALITY; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; OBSERVATIONAL STUDY; OPPORTUNISTIC INFECTION; QUALITY OF LIFE; RESPIRATORY TRACT DISEASE; SEPSIS; SEX DIFFERENCE; SUICIDE; SUICIDE ATTEMPT; THYROID DISEASE; ULCERATIVE COLITIS; URINARY TRACT INFECTION; WALKING AID; ADOLESCENT; FACTUAL DATABASE; MIDDLE AGED; SOLDIER; STATISTICS AND NUMERICAL DATA; UNITED STATES; YOUNG ADULT;

ADOLESCENT; ADULT; CAUSE OF DEATH; COHORT STUDIES; COMORBIDITY; DATABASES, FACTUAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MILITARY PERSONNEL; MULTIPLE SCLEROSIS; UNITED STATES; UNITED STATES DEPARTMENT OF DEFENSE; YOUNG ADULT;

EID: 84947600238     PISSN: 22110348     EISSN: 22110356     Source Type: Journal    
DOI: 10.1016/j.msard.2015.08.005     Document Type: Article

References (36)

1. S. Bahmanyar, S.M. Montgomery, J. Hillert, A. Ekbom, and T. Olsson Cancer risk among patients with multiple sclerosis and their parents Neurology 72 2009 1170 1177
2. R. Berkovich, D. Subhani, and L. Steinman Autoimmune comorbid conditions in multiple sclerosis US Neurol. 7 2011 132 138
3. G. Bloomgren, B. Sperling, K. Cushing, and M. Wenten Assessment of malignancy risk in patients with multiple sclerosis treated with intramuscular interferon beta-1a: retrospective evaluation using a health insurance claims database and postmarketing surveillance data Ther. Clin. Risk Manag. 8 2012 313 321
4. Capkun G., Lahoz R., Chen W., Moore A., Bischof D., Geissbuehler Y., et al., 2014. Comorbidities in patients with multiple sclerosis compared with the general population: retrospective analysis of the US MarketScan Database. Poster presented at the joint European Committee for Treatment and Research in Multiple Sclerosis-Americas Committee for Treatment and Research in Multiple Sclerosis meeting, Boston, USA, 10-13 September 2014, Poster number 179.
5. B.J. Chastek, M. Oleen-Burkey, and M.V. Lopez-Bresnahan Medical chart validation of an algorithm for identifying multiple sclerosis relapse in healthcare claims J. Med. Econ. 13 2010 618 625
6. C.F. Christiansen Risk of vascular disease in patients with multiple sclerosis: a review Neurol. Res. 34 2012 746 753
7. C.F. Christiansen, S. Christensen, D.K. Farkas, M. Miret, H.T. Sorensen, and L. Pedersen Risk of arterial cardiovascular diseases in patients with multiple sclerosis: a population-based cohort study Neuroepidemiology 35 2010 267 274
8. K.A. Dorrance, S. Ramchandani, N. Neil, and H. Fisher Leveraging the military health system as a laboratory for health care reform Mil. Med. 178 2013 142 145
9. H. Eyre, R. Kahn, R.M. Robertson, N.G. Clark, C. Doyle, Y. Hong, and et al. Preventing cancer, cardiovascular disease, and diabetes: a common agenda for the American Cancer Society, the American Diabetes Association, and the American Heart Association Circulation 109 2004 3244 3255
10. D.S. Goodwin, M. Corwin, D. Kaufman, H. Golub, S. Reshef, M.J. Rametta, and et al. Causes of death among commercially insured multiple sclerosis patients in the United States PLoS One 9 2014 e105207
11. A.E. Handel, and S.V. Ramagopalan Multiple sclerosis and risk of cancer: a meta-analysis J. Neurol. Neurosurg. Psychiatry 81 2010 1413 1414
12. C. Holmen, F. Piehl, J. Hillert, A. Fogdell-Hahn, M. Lundkvist, E. Karlberg, and et al. A Swedish national post-marketing surveillance study of natalizumab treatment in multiple sclerosis Mult. Scler. 17 2011 708 719
13. E. Jadidi, M. Mohammadi, and T. Moradi High risk of cardiovascular diseases after diagnosis of multiple sclerosis Mult. Scler. 19 2013 1336 1340
14. S.S. Jick, L. Li, G.J. Falcone, Z.P. Vassilev, and M.A. Wallander Mortality of patients with multiple sclerosis: a cohort study in UK primary care J. Neurol. 261 2014 1508 1517
15. D.W. Kaufman, S. Reshef, H.L. Golub, M. Peucker, M.J. Corwin, D.S. Goodin, and et al. Survival in commercially insured multiple sclerosis patients and comparator subjects in the US Mult. Scler. Relat. Disord. 3 2014 364 371
16. E. Kingwell, C. Bajdik, N. Phillips, F. Zhu, J. Oger, S. Hashimoto, and et al. Cancer risk in multiple sclerosis: findings from British Columbia, Canada Brain 135 2012 2973 2979
17. E. Kingwell, M. van der Kop, Y. Zhao, A. Shirani, F. Zhu, J. Oger, and et al. Relative mortality and survival in multiple sclerosis: findings from British Columbia, Canada J. Neurol. Neurosurg. Psychiatry 83 2012 61 66
18. A. Lalmohamed, M.T. Bazelier, T.P. Van Staa, B.M. Uitdehaag, H.G. Leufkens, A. De Boer, and et al. Causes of death in patients with multiple sclerosis and matched referent subjects: a population-based cohort study Eur. J. Neurol. 19 2012 1007 1014
19. C. Lebrun, M. Debouverie, P. Vermersch, P. Clavelou, L. Rumbach, J. de Seze, and et al. Cancer risk and impact of disease-modifying treatments in patients with multiple sclerosis Mult. Scler. 14 2008 399 405
20. R.A. Marrie, J. Cohen, O. Stuve, M. Trojano, P.S. Sorensen, S. Reingold, and et al. A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: overview Mult. Scler. 21 2015 263 281
21. R.A. Marrie, L. Elliott, J. Marriott, M. Cossoy, J. Blanchard, A. Tennakoon, and et al. Dramatically changing rates and reasons for hospitalization in multiple sclerosis Neurology 83 2014 929 937
22. R.A. Marrie, N. Reider, J. Cohen, O. Stuve, M. Trojano, P.S. Sorensen, and et al. A systematic review of the incidence and prevalence of cancer in multiple sclerosis Mult. Scler. 21 2015 294 304
23. M.G. Marrosu, E. Cocco, M. Lai, G. Spinicci, M.P. Pischedda, and P. Contu Patients with multiple sclerosis and risk of type 1 diabetes mellitus in Sardinia, Italy: a cohort study Lancet. 359 2002 1461 1465
24. S. Montgomery, J. Hillert, and S. Bahmanyar Hospital admission due to infections in multiple sclerosis patients Eur J Neurol. 20 2013 1153 1160
25. Multiple Sclerosis International Federation, 2013. Atlas of MS 2013: Mapping multiple sclerosis around the world.
26. N.M. Nielsen, K. Rostgaard, S. Rasmussen, N. Koch-Henriksen, H.H. Storm, M. Melbye, and et al. Cancer risk among patients with multiple sclerosis: a population-based register study Int. J. Cancer 118 2006 979 984
27. D. Ontaneda, C. Hara-Cleaver, R.A. Rudick, J.A. Cohen, and R.A. Bermel Early tolerability and safety of fingolimod in clinical practice J. Neurol. Sci. 15 2012 167 172
28. S.B. Patten, C.A. Beck, J.V. Williams, C. Barbui, and L.M. Metz Major depression in multiple sclerosis: a population-based perspective Neurology 61 2003 1524 1527
29. A. Rodriguez-Antiguedad Zarranz, M. Mendibe Bilbao, C. Llarena Gonzalez, and C. Audicana Mortality and cause of death in multiple sclerosis: findings from a prospective population-based cohort in Bizkaia, Basque Country, Spain Neuroepidemiology 42 2014 219 225
30. Social Security Administration, 2014. Social Security: Medicare. (http://www.ssa.gov/pubs/EN-05-10043.pdf) (accessed 14.10.14).
31. X. Song, G. Capkun-Niggli, B.H. Johnson, K. Kahler, and D. Krapfenbauer Medical and pharmacy claims-based algorithms for identifying patients with multiple sclerosis Value Health 16 2013 A111
32. Stewart D.B. 2005. Military Personnel: reporting additional service member demographics could enhance congressional oversight: United States Government Accountability Office.
33. S. Suissa Immortal time bias in pharmaco-epidemiology Am. J. Epidemiol. 167 2008 492 499
34. M.L. Sumelahti, M. Hakama, I. Elovaara, and E. Pukkala Causes of death among patients with multiple sclerosis Mult. Scler. 16 2010 1437 1442
35. Truven Health Analytics. 2012. Data for Healthcare Research. (http://truvenhealth.com/portals/0/assets/ACRS-11223-0912-MarketScanResearch-SS-Web.pdf) (accessed on 26.06.14).
36. World Health Organization, 2010. International Statistical Classification of Diseases and Related Health Problems 10th Revision. (http://apps.who.int/classifications/icd10/browse/2010/en) (accessed 26.06.14).